Tuberculosis News and Research

Latest Tuberculosis News and Research

Greece faces return of malaria, other public health issues since 2009 economic crash

The Wall Street Journal examines how "Greece has seen decades of advances in public health rolled back, as a flood of illegal immigrants, a dysfunctional government and budget cuts ravage a once proud health-care system."

15 Nov 2012

Tuberculosis pathogen has an ingenious defence mechanism against oxygen

Flemish biologists lead by Joris Messens (VIB / Vrije Universiteit Brussel) have discovered that Mycobacterium tuberculosis - the bacterium that causes tuberculosis - has an ingenious defence mechanism against oxygen. This knowledge is important in the search for a treatment for tuberculosis. 9.4 million people are infected with tuberculosis annually and 1.7 million people die as a result.

15 Nov 2012

Global health community should save AMFm because it saves lives

The Affordable Medicines Facility-malaria began as a pilot program in 2010 to "provide a 'co-payment' to the manufacturers of [artemisinin-based combination therapies (ACTs)], thereby allowing commercial wholesalers and private or government health services to purchase the drugs at a fraction of the already low negotiated price," Kenneth Arrow, a Nobel laureate in economic sciences in 1972 and an emeritus professor of economics at Stanford University, writes in a New York Times opinion piece.

15 Nov 2012

BMJ examines history, future of Global Fund to Fight AIDS, Tuberculosis and Malaria

The BMJ examines the history of fraud allegations against the Global Fund to Fight AIDS, Tuberculosis and Malaria and the organization's ongoing reform efforts.

14 Nov 2012

U.N., partners call for greater efforts to fight number one killer of children on World Pneumonia Day

On World Pneumonia Day (WPD), recognized on November 12, "the United Nations and its partners ... called for greater efforts to eradicate pneumonia, the number one killer of children under the age of five," the U.N. News Centre reports.

14 Nov 2012

International community must step up fight against TB in Southern African region

"With $2.5 trillion in mineral reserves, South Africa has the largest mining sector in the world," but "[t]he work can be devastatingly toxic for the body," with "inhumane and untenable" working conditions, Archbishop Desmond Tutu, archbishop emeritus of Cape Town, South Africa, writes in a Wall Street Journal opinion piece.

9 Nov 2012

Elevated ST2 biomarker levels strongly indicate heart failure and mortality in HIV patients

Critical Diagnostics, makers of the Presage ST2 Assay, announced today that during a presentation at the American Heart Association Scientific Sessions in Los Angeles, the results of a study demonstrated that elevated levels of the biomarker ST2 in HIV patients was strongly indicative of the development of heart failure and mortality.

9 Nov 2012

Key areas of disease neglected by UK funding for infectious diseases

UK funding for infectious diseases research is neglecting some of the diseases that result in the highest rates of death and disability, according to an Article published Online First in The Lancet Infectious Diseases.

8 Nov 2012

Teva announces additional data from QNASL Phase III program on seasonal allergic rhinitis

Teva Pharmaceutical Industries Ltd. announced today that additional data from the Phase III clinical program for QNASL- (beclomethasone dipropionate) Nasal Aerosol will be presented at the 2012 Annual Meeting of the American College of Allergy, Asthma and Immunology (ACAAI) in Anaheim, CA on November 8-13, 2012.

7 Nov 2012

Aidspan publishes new issue of 'Global Fund Observer'

Aidspan, an independent watchdog of the Global Fund to Fight AIDS, Tuberculosis and Malaria, on Monday published Issue 201 of its "Global Fund Observer."

7 Nov 2012

IRIN examines intellectual property protection in South Africa

IRIN examines how patents and intellectual property protection in South Africa affects patients' access to medicines. "A form of intellectual property protection, patents are typically awarded to companies that can prove their product is new," IRIN writes, adding, "Not so in South Africa, say activists and researchers, who claim the country's patent system allows pharmaceutical companies to apply for new patents on existing drugs based on immaterial changes -- like adding table salt to a formulation or changing a pill's color."

7 Nov 2012

FDA approves Pfizer’s XELJANZ to treat rheumatoid arthritis

Pfizer Inc. has received approval from the U.S. Food and Drug Administration (FDA) for XELJANZ (tofacitinib citrate) 5 mg twice daily for the treatment of adults with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate response or intolerance to methotrexate.

6 Nov 2012

Pfizer receives FDA approval for Xeljanz to treat rheumatoid arthritis

The U.S. Food and Drug Administration today approved Xeljanz (tofacitinib) to treat adults with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate response to, or who are intolerant of, methotrexate.

6 Nov 2012

IRIN examines controversy surround AMFm

IRIN examines the controversy surrounding the Affordable Medicines Facility-malaria (AMFm), writing, "The argument over the way it operates has reignited ahead of a board meeting of the [Global Fund to Fight AIDS, Tuberculosis and Malaria] on 14-15 November, which is due to assess the success of the project and its reliance on private sector providers."

6 Nov 2012

USAID newsletter focuses on TB

The November 2012 issue of USAID's "Global Health News" newsletter focuses on tuberculosis (TB).

6 Nov 2012

USAID to triple financial support for PAHO/WHO Regional TB Program

According to a Pan American Health Organization (PAHO) and WHO joint press release, USAID "has tripled its financial support for the Pan American Health Organization/World Health Organization (PAHO/WHO) Regional Tuberculosis Program, which seeks to prevent 15,000 deaths from tuberculosis in Latin America and the Caribbean over the next five years and reduce the incidence of this disease."

3 Nov 2012

Weill Cornell researchers awarded Grand Challenges Explorations grants

Weill Cornell Medical College announced today that it is a Grand Challenges Explorations winner, an initiative funded by the Bill & Melinda Gates Foundation.

3 Nov 2012

GlobalPost interviews director of WHO Stop TB Department about future of global response

In an interview with GlobalPost's "Global Pulse" blog, Mario Raviglione, director of the WHO's Stop TB Department, explains "why the fight against [tuberculosis (TB)] is at a crossroads."

3 Nov 2012

Intensified antibiotic treatment can improve prognosis of patients with TB meningitis

Researchers from the Radboud UMC have conducted the first study globally to show that intensified antibiotic treatment can improve the prognosis of patients with tuberculous (TB) meningitis, the most severe form of TB which carries a mortality of up to 50%.

3 Nov 2012

Mass spectrometry can help visualize how drugs work inside living cells to kill infectious microbes

Weill Cornell Medical College researchers report that mass spectrometry, a tool currently used to detect and measure proteins and lipids, can also now allow biologists to "see" for the first time exactly how drugs work inside living cells to kill infectious microbes.

3 Nov 2012

Tuberculosis News and Research

Latest Tuberculosis News and Research

Greece faces return of malaria, other public health issues since 2009 economic crash

Tuberculosis pathogen has an ingenious defence mechanism against oxygen

Global health community should save AMFm because it saves lives

BMJ examines history, future of Global Fund to Fight AIDS, Tuberculosis and Malaria

U.N., partners call for greater efforts to fight number one killer of children on World Pneumonia Day

International community must step up fight against TB in Southern African region

Elevated ST2 biomarker levels strongly indicate heart failure and mortality in HIV patients

Key areas of disease neglected by UK funding for infectious diseases

Teva announces additional data from QNASL Phase III program on seasonal allergic rhinitis

Aidspan publishes new issue of 'Global Fund Observer'

IRIN examines intellectual property protection in South Africa

FDA approves Pfizer’s XELJANZ to treat rheumatoid arthritis

Pfizer receives FDA approval for Xeljanz to treat rheumatoid arthritis

IRIN examines controversy surround AMFm

USAID newsletter focuses on TB

USAID to triple financial support for PAHO/WHO Regional TB Program

Weill Cornell researchers awarded Grand Challenges Explorations grants

GlobalPost interviews director of WHO Stop TB Department about future of global response

Intensified antibiotic treatment can improve prognosis of patients with TB meningitis

Mass spectrometry can help visualize how drugs work inside living cells to kill infectious microbes

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Tuberculosis News and Research

Latest Tuberculosis News and Research

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in